Alex is a psychologist based in New York City. He provides ketamine assisted psychotherapy (KAP) and psychedelic harm reduction and integration (PHRI) in his private practice. He is a lead therapist, traveling consultant, trainer, and mentor on various FDA-approved research studies investigating psilocybin assisted therapy.

He is also a Lead Session Monitor on FDA-approved trials investigating LSD for Generalized Anxiety Disorder and Major Depressive Disorder. He trained three separate cohorts for their psilocybin facilitator’s license in Oregon, and now teaches as a faculty member in Fluence’s Colorado facilitator training program.

Alex is interested in the integration of psychedelic therapy with psychoanalytic and attachment-based theories. His clinical training focused on providing mental health services in low-fee clinics and hospitals to traditionally underserved communities in the Bronx, Brooklyn, and Nassau County.